GeneTex
  • Country / Location Selection

United States (US)

CD2BP2 (N Terminus) blocking peptide

Cat. No. GTX89547-PEP

Species

Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX89547.

PROPERTIES

Form

Lyophilized powder

Buffer

Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O.

Preservative

No preservative

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

PKRKVTFQGVGDE-C

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Cd2 Cytoplasmic Tail Binding Protein 2 , Fwp010 , Lin1 , Ppp1R59 , Snu40 , U5-52K , Cd2Bp2

Background

This gene encodes a bi-functional protein. In the cytoplasm, the encoded protein binds the cytoplasmic tail of human surface antigen CD2 via its C-terminal GYF domain, and regulate CD2-triggered T lymphocyte activation. In the nucleus, this protein is a component of the U5 small nuclear ribonucleoprotein complex and is involved in RNA splicing. A pseudogene has been identified on chromosome 7. Alternative splicing results in multiple transcript variants but their biological validity has not been determined. [provided by RefSeq, Nov 2008]

Research Area

REFERENCE

There are currently no references for CD2BP2 (N Terminus) blocking peptide (GTX89547-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for CD2BP2 (N Terminus) blocking peptide (GTX89547-PEP). Be the first to share your experience with this product.
Package List Price ($)
$ 239